Cargando…
Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
Autor principal: | Healthcare Engineering, Journal of |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533239/ https://www.ncbi.nlm.nih.gov/pubmed/37772002 http://dx.doi.org/10.1155/2023/9820474 |
Ejemplares similares
-
NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
por: Zhong, Yan, et al.
Publicado: (2022) -
Retracted: CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: lncRNA MSC-AS1 Aggravates Diabetic Nephropathy by Regulating the miR-325/CCNG1 Axis
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: mir-204-5p Acts as a Tumor Suppressor by Targeting DNM2 in Osteosarcoma Cells
por: Engineering, Journal of Healthcare
Publicado: (2023) -
Retracted: Analysis on Value of Applying Serum miR-144 and miR-221 Levels in Diagnosing Atherosclerosis
por: Engineering, Journal of Healthcare
Publicado: (2023)